Skip to main content

Table 7 Changes of NLR in patients of response and non-response groups

From: Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group Trend
Decrease Increase Total
Response 36 52 88
Non-response 14 17 31
Total 50 69 119
P value 0.679